Abstract
We report the case of a 29-week preterm infant with PHACE (posterior fossa malformations, hemangionas, arterial anomalies, cardiac anomalies, eye anomalies) syndrome. PHACE syndrome is a neurocutaneous disorder with large facial segmental hemangionas associated with anomalies of the brain, eye, heart and aorta. The hemangiomas in our patient were problematic, distorting the airway and interfering with respirations to the point of requiring mechanical ventilation. Consultation with several different centers with medical expertize in treatment of congenital hemangiomas revealed different views on the best management strategy. In this infant, the hemangiomas progressed with failure to involute despite currently recommended therapy including corticosteroids and vincristine. Therefore, the infant was treated with propranolol and had significant regression of the hemangiomas. The use of propranolol for the treatment of infantile hemangiomas is reviewed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Metry D, Heyer G, Hess C, Garzon M, Haggstrom A, Frommelt P et al. Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics 2009; 124: 1447–1456.
Léauté-Labrèze CA . Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358 (24): 2649–2651.
Sans V, Léauté-Labrèze C . Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009; 124: e423–e431.
Amir J, Metzker A, Krikler R, Reisner SH . Strawberry hemangioma in preterm infants. Pediatr Dermatol 1986; 3 (4): 331–332.
Metry DW, Haggstrom AN, Drolet BA, Baselga E, Chamlin S, Garzon M et al. A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications. Am J Med Genet A 2006; 140 (9): 975–986.
Haggstrom AN, Garzon MC, Baselga E, Chamlin SL, Frieden IJ, Holland K et al. Risk for PHACE syndrome in infants with large facial hemangiomas. Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics 2010; 126: e418–e426.
Frieden IJ, Reese V, Cohen D . PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 1996; 132: 307–311.
Poetke M, Frommeld T, Berlien HP . PHACE syndrome: new views on diagnostic criteria. Eur J Pediatr Surg 2002; 12: 366–374.
Metry DW, Dowd CF, Barkovich AJ, Frieden IJ . The many faces of PHACE syndrome. J Pediatr 2001; 139: 117–123.
Bennett ML, Fleischer Jr AB, Chamlin SL, Frieden IJ . Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 2001; 137: 1208–1213.
Lawley LP . Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2009; 26 (5): 610–614.
Mousa W, Kues K, Haas E, Lauerer P, Pavlakovic H, Schön MP et al. Successful treatment of hemagioma with propranolol. J Dtsch Dermatol Ges 2010; 8 (3): 184–186.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interests.
Rights and permissions
About this article
Cite this article
Solomon, T., Ninnis, J., Deming, D. et al. Use of propranolol for treatment of hemangiomas in PHACE syndrome. J Perinatol 31, 739–741 (2011). https://doi.org/10.1038/jp.2011.28
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2011.28
Keywords
This article is cited by
-
Infantile Hemangiomas
American Journal of Clinical Dermatology (2013)